Clinical significance of topoisomerase 2A expression and gene change in operable invasive breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s13277-015-3390-6.pdf
Reference25 articles.
1. Lan J, Huang HY, Lee SW, Chen TJ, Tai HC, Hsu HP, et al. TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma. Tumor Biol. 2014;35(1):179–87.
2. Zaczek A, Welnicka-Jaskiewicz M, Bielawski KP, Jaskiewicz J, Badzio A, Olszewski W, et al. Gene copy numbers of HER family in breast cancer. J Cancer Res Clin Oncol. 2008;134(2):271–9.
3. Sherman-Baust CA, Kuhn E, Valle BL. Shih Iem, Kurman RJ, Wang TL, Amano T, Ko MS, Miyoshi I. A genetically, engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development. J Pathol. 2014;233(3):228–37.
4. Karnes RJ, Cheville JC, Ida CM, Sebo TJ, Nair AA, Tang H, et al. The ability of biomarkers to predict systemic progression in men with high-risk prostate cancer treated surgically is dependent on ERG status. Cancer Res. 2010;70(22):8994–9002.
5. Moiseyenko VM, Volkov NM, Suspistin EN, Yanus GA, Iyevleva AG, Kuligina ES, et al. Evidence for predictive role of BRCA1 and Qtubiii in gastric cancer. Med Oncol. 2013;30(2):545.
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer;Breast Cancer Research and Treatment;2022-03-16
2. Evaluation of immunohistochemical expression of topoisomerase II alpha protein in patients with breast cancer and its correlation with different prognostic factors;Medical Journal of Babylon;2022
3. A careful reassessment of anthracycline use in curable breast cancer;npj Breast Cancer;2021-10-08
4. Extensive analysis of the molecular biomarkers excision repair cross complementing 1, ribonucleotide reductase M1, β-tubulin III, thymidylate synthetase, and topoisomerase IIα in breast cancer;Medicine;2021-04-09
5. Prognostic Value of Topoisomerase 2-Alpha and B-Myb in Early Breast Cancer Treated with Adjuvant Chemotherapy;Acta Clinica Croatica;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3